PGF and preeclampsia: This should be evaluated in prospective trials and is the subject of the current PAPAGAIO (Preterm preeclampsia: Placental Growth factor for reduction of Adverse Outcomes) trial in Brazil, India, and Sierra Leone using these POC tests.